Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CVRx (CVRX) Net Income towards Common Stockholders (2020 - 2025)

CVRx (CVRX) has 6 years of Net Income towards Common Stockholders data on record, last reported at -$12.0 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 12.09% year-over-year to -$12.0 million; the TTM value through Dec 2025 reached -$53.3 million, up 11.09%, while the annual FY2025 figure was -$53.3 million, 11.09% up from the prior year.
  • Net Income towards Common Stockholders reached -$12.0 million in Q4 2025 per CVRX's latest filing, up from -$12.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$6.1 million in Q3 2021 and bottomed at -$22.2 million in Q1 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$12.0 million, with a median of -$11.2 million recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: crashed 475.86% in 2021, then soared 37.95% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$10.6 million in 2021, then increased by 0.32% to -$10.5 million in 2022, then grew by 13.03% to -$9.2 million in 2023, then dropped by 16.37% to -$10.7 million in 2024, then decreased by 12.09% to -$12.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$12.0 million in Q4 2025, -$12.9 million in Q3 2025, and -$14.7 million in Q2 2025.